Indicated for: hereditary angioedema
Route of administration: injectable / infusion
Substance: human C1 esterase inhibitor (C1 esterase inhibitor)
ATC: B02AB03 (Blood and blood forming organs | Antifibrinolytics | Proteinase inhibitors)
Human C1 esterase inhibitor is used for the treatment of hereditary angioedema, a genetic condition characterized by recurrent episodes of severe swelling. It works by regulating the activity of the complement system and preventing its excessive activation.
The medication is administered intravenously, as directed by a doctor. It is important to monitor the patient for adverse reactions during the infusion.
Side effects may include headache, nausea, dizziness, or injection site reactions. In rare cases, severe allergic reactions may occur.
This medication is not recommended for patients with hypersensitivity to human plasma proteins or severe IgA deficiency.